News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
413,664 Results
Type
Article (26862)
Company Profile (60)
Press Release (386742)
Multimedia
Podcasts (25)
Webinars (7)
Section
Business (114937)
Career Advice (455)
Deals (19339)
Drug Delivery (51)
Drug Development (50752)
Employer Resources (47)
FDA (12886)
Job Trends (8733)
News (203591)
Policy (21116)
Tag
Academia (1785)
Accelerated approval (3)
Adcomms (8)
Allergies (74)
Alliances (30822)
ALS (57)
Alzheimer's disease (837)
Antibody-drug conjugate (ADC) (53)
Approvals (12953)
Artificial intelligence (175)
Autoimmune disease (10)
Automation (4)
Bankruptcy (148)
Best Places to Work (7046)
BIOSECURE Act (5)
Biosimilars (49)
Biotechnology (40)
Bladder cancer (62)
Brain cancer (17)
Breast cancer (196)
Cancer (1473)
Cardiovascular disease (119)
Career advice (413)
Career pathing (13)
CAR-T (70)
Cell therapy (212)
Cervical cancer (13)
Clinical research (43119)
Collaboration (478)
Compensation (132)
Complete response letters (9)
COVID-19 (1564)
CRISPR (12)
C-suite (144)
Cystic fibrosis (44)
Data (1567)
Decentralized trials (2)
Denatured (17)
Depression (31)
Diabetes (177)
Diagnostics (3738)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (57)
Drug pricing (54)
Drug shortages (21)
Duchenne muscular dystrophy (62)
Earnings (40886)
Editorial (20)
Employer branding (6)
Employer resources (44)
Events (55249)
Executive appointments (466)
FDA (13892)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (430)
Gene editing (36)
Generative AI (10)
Gene therapy (136)
GLP-1 (420)
Government (3107)
Grass and pollen (4)
Guidances (38)
Healthcare (12532)
Huntington's disease (10)
IgA nephropathy (18)
Immunology and inflammation (40)
Indications (21)
Infectious disease (1636)
Inflammatory bowel disease (86)
Inflation Reduction Act (4)
Influenza (28)
Intellectual property (55)
Interviews (40)
IPO (7857)
IRA (19)
Job creations (1979)
Job search strategy (384)
Kidney cancer (7)
Labor market (10)
Layoffs (174)
Leadership (4)
Legal (4239)
Liver cancer (61)
Lung cancer (235)
Lymphoma (101)
Machine learning (3)
Management (17)
Manufacturing (117)
MASH (50)
Medical device (13012)
Medtech (13016)
Mergers & acquisitions (11811)
Metabolic disorders (445)
Multiple sclerosis (55)
NASH (11)
Neurodegenerative disease (50)
Neuropsychiatric disorders (9)
Neuroscience (1179)
NextGen: Class of 2025 (4017)
Non-profit (2838)
Now hiring (16)
Obesity (224)
Opinion (70)
Ovarian cancer (54)
Pain (65)
Pancreatic cancer (54)
Parkinson's disease (92)
Partnered (12)
Patents (120)
Patient recruitment (82)
Peanut (37)
People (36835)
Pharmaceutical (17)
Pharmacy benefit managers (11)
Phase I (12345)
Phase II (18650)
Phase III (15323)
Pipeline (716)
Policy (59)
Postmarket research (1761)
Preclinical (3963)
Press Release (19)
Prostate cancer (78)
Psychedelics (17)
Radiopharmaceuticals (164)
Rare diseases (188)
Real estate (3227)
Recruiting (16)
Regulatory (15267)
Reports (18)
Research institute (1639)
Resumes & cover letters (48)
Rett syndrome (2)
RNA editing (2)
RSV (20)
Schizophrenia (52)
Series A (72)
Series B (52)
Service/supplier (3)
Sickle cell disease (21)
Special edition (3)
Spinal muscular atrophy (102)
Sponsored (13)
Startups (2316)
Stomach cancer (9)
Supply chain (39)
Tariffs (11)
The Weekly (8)
Vaccines (364)
Venture capitalists (14)
Weight loss (143)
Women's health (17)
Worklife (4)
Date
Today (96)
Last 7 days (474)
Last 30 days (1497)
Last 365 days (19523)
2025 (6134)
2024 (21013)
2023 (24076)
2022 (32787)
2021 (35123)
2020 (34389)
2019 (29942)
2018 (23046)
2017 (20515)
2016 (19611)
2015 (23129)
2014 (17581)
2013 (14711)
2012 (15834)
2011 (16252)
2010 (14817)
Location
Africa (394)
Alabama (18)
Alaska (2)
Arizona (119)
Arkansas (10)
Asia (34728)
Australia (5069)
California (3180)
Canada (1287)
China (412)
Colorado (164)
Connecticut (176)
Delaware (114)
Europe (54642)
Florida (549)
Georgia (126)
Idaho (33)
Illinois (363)
India (19)
Indiana (224)
Iowa (3)
Japan (141)
Kansas (73)
Kentucky (12)
Louisiana (7)
Maine (29)
Maryland (641)
Massachusetts (2217)
Michigan (106)
Minnesota (275)
Mississippi (2)
Missouri (53)
Montana (18)
Nebraska (18)
Nevada (34)
New Hampshire (60)
New Jersey (1179)
New Mexico (9)
New York (989)
North Carolina (575)
North Dakota (4)
Northern California (1388)
Ohio (132)
Oklahoma (3)
Oregon (23)
Pennsylvania (842)
Puerto Rico (7)
Rhode Island (24)
South America (573)
South Carolina (20)
Southern California (1233)
Tennessee (77)
Texas (548)
United States (13154)
Utah (115)
Virginia (80)
Washington D.C. (40)
Washington State (231)
West Virginia (3)
Wisconsin (43)
413,664 Results for "saluda medical pty ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia
April 2, 2025
·
5 min read
Press Releases
Saluda Medical Announces Closing of $100 Million Financing
January 10, 2025
·
2 min read
Press Releases
Saluda Medical Announces Presentation of New Clinical Data at the 2025 NANS Annual Meeting
February 5, 2025
·
4 min read
Press Releases
Saluda Medical Receives FDA Approval for First Automated Programming Platform in SCS
January 23, 2025
·
3 min read
Business
Saluda Medical Appoints Jim Erickson as Chief Financial Officer
Saluda Medical, Inc. announced the appointment of Jim Erickson as Chief Financial Officer.
December 14, 2023
·
3 min read
BioMidwest
Saluda Medical Announces Late Breaking Data at NANS 2024 Annual Meeting
Saluda Medical, Inc. today announced the company’s data will be presented at the North American Neuromodulation Society (NANS) 2024 Annual Meeting, taking place January 18-21.
January 16, 2024
·
3 min read
FDA
Saluda Medical Receives FDA Approval for Evoke® System MRI Labeling
Saluda Medical, Inc. (“Saluda Medical”) today announced that the U.S. Food and Drug Administration (FDA) has approved MRI conditional labeling for the Evoke® System, the first and only precision, dose-control spinal cord stimulation (SCS) therapy powered by SmartLoop™ technology.
September 26, 2023
·
2 min read
Press Releases
Saluda Medical Announces Presentation of Two Chronic Pain Biomarker-Based Analyses at ASPN 2024 Annual Conference
July 18, 2024
·
4 min read
Saluda Medical Announces Presentation of 36-Month Trial Data at NANS 2023 Annual Meeting
Saluda Medical Pty Limited (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation, today announced that late-breaking data from the landmark EVOKE Clinical Trial was presented at the 2023 North American Neuromodulation Society (NANS) Annual Meeting.
January 17, 2023
·
4 min read
Press Releases
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
March 3, 2025
·
5 min read
1 of 41,367
Next
